Leslie Sharp BS, PhD

Dr. Leslie Sharp has extensive experience in the biotechnology and pharmaceutical industry. Most recently Dr. Sharp was an industry consultant, providing expertise on portfolio strategy, drug discovery, translational research, and early clinical development of biological therapies for cancer to both biotechnology and pharmaceutical companies. She previously served as Associate Director of Oncology at the Genomics Institute of the Novartis Research Foundation and at positions of increasing responsibility including as director level Associate Research Fellow at Pfizer.

Dr. Sharp has led multiple discovery and early clinical development programs in oncology biologics and has particular expertise in immunomodulatory antibodies and antibody-drug-conjugates. Dr. Sharp earned her Ph.D. from the University of California, San Diego focusing on the role of signaling pathways in T cell development. Her post-doctoral work at The Scripps Research Institute examined the role of T cells in wound healing.